Concepedia

Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): Analysis of factors associated with response

James M. Foran, David Cunningham, Bertrand Coiffier, Philippe Solal‐Céligny, F Reyes, Michele Ghielmini, Peter Johnson, Christian Gisselbrecht, Mike Bradburn, J. Matthews,

Annals of Oncology · 2000 · 106 citations · 15 references

DOI

Concepts

References

15

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

, , +10

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]

NL Harris, ES Jaffe, H Stein et al. · Blood · 1994 · 6.4K citations · Full text

, , +14

A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

New England Journal of Medicine · 1993 · 5K citations · Full text

, , +15

National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usage

Cancer · 1982 · 3.1K citations · Full text

, , +17

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

Peter McLaughlin, A.J. Grillo-López, Brian K. Link et al. · Journal of Clinical Oncology · 1998 · 2.8K citations

, , +17